Prognostic Biomarkers for Precision Medicine in Heart Transplant: Is Galectin-3 the One?
Rev Esp Cardiol (Engl Ed). 2019 Nov;72(11):889-891.
doi: 10.1016/j.rec.2019.05.005.
Epub 2019 Jun 11.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Medicine, Sheba Medical Centre, Tel Hashomer, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- 2 Department of Cardiovascular Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States. Electronic address: pereira.naveen@mayo.edu.
No abstract available
MeSH terms
-
Biomarkers / metabolism
-
Blood Proteins
-
Galectin 3 / metabolism*
-
Galectins
-
Graft Rejection / diagnosis
-
Graft Rejection / metabolism*
-
Heart Failure / metabolism
-
Heart Failure / surgery*
-
Heart Transplantation*
-
Humans
-
Precision Medicine / methods*
-
Prognosis
Substances
-
Biomarkers
-
Blood Proteins
-
Galectin 3
-
Galectins
-
LGALS3 protein, human